To further explore the potential role of RPL6 in gene therapy of gastric cancer, SGC7901 and AGS cells were transfected with RPL6-specific siRNA and the mixed pool of G418-resistant cell variants was produced. This evidence concerns the gene RPL6 and gastric cancer.